Bhirud Pritee H, Chellam Shrividya, Mote Mandar N, Toal Pratibha V
Full Time Anaesthesia Consultant, BARC Hospital, Mumbai, Maharashtra, India.
Senior Resident, BARC Hospital, Mumbai, Maharashtra, India.
J Anaesthesiol Clin Pharmacol. 2020 Jan-Mar;36(1):78-82. doi: 10.4103/joacp.JOACP_129_18. Epub 2020 Feb 18.
Our aim was to study the effects of a low-dose bolus (0.5 mcg/kg) of dexmedetomidine followed by two different infusion doses (0.25, 0.5 mcg/kg/h) on spinal anesthesia, sedation, hemodynamics and side effects.
Eighty consenting patients were randomized into two groups A and B with 40 patients each. Patients in both groups were administered intravenous (IV) dexmedetomidine 0.5 mcg/kg over 10 min prior to SAB followed by IV dexmedetomidine 0.25 mcg/kg/h infusion (A) and 0.5 mcg/kg/h infusion (B) throughout the duration of surgery. Time for onset of sensory and motor block, duration of motor block and analgesia, time for two segment regression, intra operative hemodynamics and sedation were assessed. value less than 0.05 was taken as significant.
Onset of sensory block to T10 was 2.1 ± 0.3 min in group A and group B. Onset of motor block was 4.6 ± 0.9 min in group A and 4.3 ± 0.9 min in group B. Duration of motor block in group A was 235.6 ± 12.4 min compared to group B which was 245.3 ± 9.3 min. Time for 2 segment regression in group A was 139.7 ± 29.7 min compared to group B which was 152.3 ± 18.7 min. Total duration of analgesia was 259.3 ± 92.4 min in group A and 273.8 ± 52.3 min in group B. There was a significant reduction in heart rate and mean blood pressure compared to the baseline within both the groups. Sedation was comparable in both the groups.
IV dexmedetomidine bolus of 0.5 mcg/kg prior to subarachnoid block followed by maintenance infusion of 0.5 mcg/kg/h significantly prolonged duration of motor block, time for two segment regression, along with stable hemodynamics and adequate sedation.
我们的目的是研究低剂量推注(0.5微克/千克)右美托咪定,随后给予两种不同输注剂量(0.25、0.5微克/千克/小时)对脊髓麻醉、镇静、血流动力学及副作用的影响。
80例自愿受试患者被随机分为A、B两组,每组40例。两组患者在蛛网膜下腔阻滞(SAB)前10分钟静脉注射(IV)右美托咪定0.5微克/千克,随后在整个手术过程中,A组以0.25微克/千克/小时的速度输注右美托咪定,B组以0.5微克/千克/小时的速度输注。评估感觉和运动阻滞起效时间、运动阻滞和镇痛持续时间、两个节段消退时间、术中血流动力学及镇静情况。P值小于0.05被视为具有统计学意义。
A组和B组感觉阻滞至T10的起效时间为2.1±0.3分钟。A组运动阻滞起效时间为4.6±0.9分钟,B组为4.3±0.9分钟。A组运动阻滞持续时间为235.6±12.4分钟,B组为245.3±9.3分钟。A组两个节段消退时间为139.7±29.7分钟,B组为152.3±18.7分钟。A组镇痛总持续时间为259.3±92.4分钟,B组为273.8±52.3分钟。与基线相比,两组患者的心率和平均血压均显著降低。两组镇静效果相当。
蛛网膜下腔阻滞前静脉注射0.5微克/千克右美托咪定推注,随后以0.5微克/千克/小时维持输注,可显著延长运动阻滞持续时间、两个节段消退时间,同时血流动力学稳定且镇静充分。